Efficacy News and Research

RSS
STARR procedure proposed as alternative operation, noninvasive surgical technique for ODS

STARR procedure proposed as alternative operation, noninvasive surgical technique for ODS

Medical marijuana hydroponics nutrients receive official US approval

Medical marijuana hydroponics nutrients receive official US approval

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

Phase III study of Afinitor tablets in patients with advanced pancreatic NET meets primary endpoint

Phase III study of Afinitor tablets in patients with advanced pancreatic NET meets primary endpoint

ZELTIQ raises $25M in Series D funding

ZELTIQ raises $25M in Series D funding

Oculus launches Microcyn Negative-Pressure Wound Therapy Solution

Oculus launches Microcyn Negative-Pressure Wound Therapy Solution

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Protox Therapeutics reports positive data from Phase 2b study of PRX302 in BPH

Protox Therapeutics reports positive data from Phase 2b study of PRX302 in BPH

Johns Hopkins professor receives $1M MSCRF grant to study glial cells for treating myelin disorders

Johns Hopkins professor receives $1M MSCRF grant to study glial cells for treating myelin disorders

ENMD-2076 demonstrates antitumor activity against murine xenograft models of CRC: Study

ENMD-2076 demonstrates antitumor activity against murine xenograft models of CRC: Study

Genes influence AIAA side effect in breast cancer survivors

Genes influence AIAA side effect in breast cancer survivors

ZymoGenetics commences Phase 2B study of PEG-Interferon lambda in hepatitis C

ZymoGenetics commences Phase 2B study of PEG-Interferon lambda in hepatitis C

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

Shionogi Pharma presents study results of PSD502 for treatment of primary PE at AUA 2010

Shionogi Pharma presents study results of PSD502 for treatment of primary PE at AUA 2010

Targeted monoclonal antibodies show promise for pancreatic and metastatic breast cancer

Targeted monoclonal antibodies show promise for pancreatic and metastatic breast cancer

Santarus commences enrollment in rifamycin SV MMX Phase III clinical program for travelers' diarrhea

Santarus commences enrollment in rifamycin SV MMX Phase III clinical program for travelers' diarrhea

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.